A Knowledge-Based Activity
ACPE UAN: 0016-0000-22-029-L01-P, 1.0 contact hour (0.1 CEUs)
1.0 AMA PRA Category 1 Credit(s)™ CME
1.0 contact hour CNE

Learning Objectives:

• Describe the mechanisms of action of prothrombin complex concentrates and identify which components are beneficial in the treatment of hemorrhage due to anticoagulation
• Summarize current evidence supporting the use of fixed-dose versus variable-dose prothrombin complex concentrate regimens in anticoagulation reversal
• Explain whether present literature affirms a fixed-dose prothrombin complex concentrate regimen confers a safety benefit over a variable-dose regimen

Speaker Disclosures

All speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial relationships with ineligible companies to disclose.